The Latest
-
Recor wins FDA panel’s backing for high blood pressure device
The advisers found the company’s renal denervation system is safe and effective, but several panelists expressed concern about the long-term durability of the treatment.
-
Bayer inks deal to commercialize Mahana’s prescription digital therapeutics
The multimillion-dollar distribution and marketing partnership comes amid a decline in funding for prescription digital therapeutic companies.
-
Zimmer Biomet CEO Hanson departs for 3M
COO Ivan Tornos will become the orthopedic device maker’s new top executive.
-
BARDA backs Satio’s work on patch-based Ebola test for use in remote settings
Satio will combine its patch-based blood collection device with Institut Pasteur de Dakar's Ebola virus immunoassay.
-
Axonics appoints Kari Keese to CFO post as Dan Dearen retires
The retirement of company co-founder Dearen is “unexpected but not concerning,” Truist analyst Richard Newitter said.
-
Medtronic raises earnings forecast amid supply chain, diabetes business improvements
The company also shared an update on the planned divestment of its monitoring and respiratory interventions segments.
-
Opinion
Harnessing molecular diagnostics to address antibiotic shortages
Diagnostic testing can play an important role in public health by stopping the dangerous squandering of effective medicines that are in short supply, says David Persing, chief medical and scientific officer at Cepheid.
-
Deep Dive
幸运飞行艇官方开奖记录网站下载-168飞艇在线历史记录查询 DTC marketing amid fight for share of growing diabetes market
As insurers cover continuous glucose monitors for more people, device-makers are taking a page from the pharma marketing playbook.
-
Agilent to wind down Resolution Bioscience liquid biopsy unit
The company will discontinue operations at the business it bought two years ago for $550 million.
-
Tandem’s chief commercial officer to resign ahead of insulin pump rollout
Brian Hansen is stepping down as Tandem prepares to roll out its new Mobi pump.
-
Q&A
Generative AI in healthcare: Google Cloud’s Amy Waldron on the tech giant’s health ambitions
Google Cloud’s Amy Waldron discussed the company’s plans — and the potential risks — for generative AI in healthcare.
-
Bruker to buy PhenomeX and its cell research tools for $108M
The life science tools sector is ripe for consolidation, according to analysts at TD Cowen.
-
Google expands AI mammography deal with iCAD
The amendment extends the original licensing agreement to 20 years and could allow the AI system to serve as a second reader.
-
Integra receives warning letter related to quality issues at Boston plant
The company recalled all products made at its Boston facility over the last five years, and hopes to restart manufacturing in the fourth quarter.
Updated Aug. 17, 2023 -
Edwards software linked to improved blood pressure control during surgery
Results of a registry analysis suggest “software monitoring may help reduce the duration and severity of intraoperative hypotension.”
-
23andMe rival warns consumer test approach misses 90% of cancer variants
The retrospective study looked at the proportion of mutations in BRCA1/2 that are covered by 23andMe’s consumer genetic test.
-
One death, 2 injuries reported in recall of Philips Trilogy ventilators
Philips warned in a previous recall about problems with the devices’ sensors that can lead to under-delivery of oxygen.
-
Medtronic’s dialysis device recall assigned to Class I by the FDA
The company contacted customers after routine manufacturing testing identified a blockage that could obstruct the catheter.
-
GE HealthCare wins FDA clearance for wireless hospital vital sign monitor
The Portrait Mobile device is one of GE HealthCare’s “first major introductions in monitoring in recent years,” according to the company.
-
Labcorp scoops up Tufts Medicine outreach lab, continuing buying spree
As the laboratory services giant continues its acquisition streak, hundreds of employees will be let go at the Boston-based academic health system.
-
Medtronic’s bid to dismiss heart device kickback claims fails, clearing case to advance
A whistleblower accused Medtronic of violating the False Claims Act by billing the government for unnecessary medical procedures.
Updated Aug. 15, 2023 -
Insulet claims EOFlow copied patch-pump design in patent suit
Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.
-
Illumina faces SEC probe over Grail acquisition 飞艇168开奖网直播结果
The securities regulator has asked for documents tied to the 2021 deal in addition to the conduct and compensation of members of Illumina and Grail management.
-
Boston Scientific’s pivotal pulsed field ablation trial expected to succeed: analysts
Positive results could position Boston Scientific to win U.S. approval for Farapulse in the second half of next year.
-
Cue Health wins $28M BARDA contract to develop rapid respiratory infection test
The company plans to launch the respiratory panel for the 2024-25 virus season and aims to break even in 2025.